Skip to main content

Table 6 Bivariate and multivariable analyses of factors associated with viral suppression among adolescent patients (n = 446) at the public hospital Addis Ababa, 2021

From: Viral suppression rate at operation triple zero (Otz) and regular art follow-Up programs and associated factors among adolescent clients of Addis Ababa Ethiopia: a comparative cross-sectional study

Variable

Categories

Viral suppression status (n = 446)

COR (95% CI)

AOR (95% CI)

P value

Suppressed

Unsuppressed

OTZ

Yes

206

17

2.26(1.223–4.16)

21.6(3.499–133.9)

0.041

No

188

35

1

1

 

Have hx of admission

Yes

22

19

0.103(0.051-0.2090

0.005(0.000- 0.050)

0.000

No

372

33

1

1

 

Alcohol use

Yes

47

21

0.20(0.106-0.376)

0.012(0.002- 0.078)

0.022

No

347

31

1

1

 

Smoke cigarette

Yes

4

10

0.043(0.013 − 0.143)

0.008(0.000 − 0.359)

0.008

No

390

42

1

1

 

Biological mother alive

Yes

168

5

6.7(2.72- 17.948)

7.5(1.502–37.491)

0.017

No

226

47

1

1

 

Discrimination

Yes

6

17

0.032(0.012- 0.086)

0.024(0.003 − 0.183)

0.001

No

388

35

1

1

 

last appointment

Schedule

22

2

32.3(7.743- 134)

18(4.120–34.271)

0.002

Unscheduled

172

50

1

1

 

Current medication regimen

ABC,3TC, LOP/r

51

1

3.59(0.820-4.541)

2.101(0.914.-11.271)

0.062

AZT/3TC, LOP/r

26

0

--

--

---

TDF/3TC/DTG

241

17

1

1

 

TDF/3TC/EFZ

16

14

0.082(0.0104-0.429)

0.025 (0.004 − 0.148)

0.000

Other combination

60

20

0.263(0.091 − 6.3)

0.210(0.0850-14.484)

0.084

  1. VL = viral load, ABC/3TC/ LOP/r = abacavir/lamivudine/lopinavir/ritonavir, AZT/3TC/ LOP/r = abacavir/lamivudine/lopinavir/ritonavir, TDF/3TC/DTG = tenofovir disoproxil fumarate/lamivudine/dolutegravir, TDF/3TC/ EFZ = tenofovir disoproxil fumarate/lamivudine/efavirenz